Skeletal Muscle Atrophy Induced by Diabetes Is Mediated by Non-Selective Channels and Prevented by Boldine

Vista sencilla de ítem
dc.contributor.authorCea, Luis A.
dc.contributor.authorVásquez, Walter
dc.contributor.authorHernández-Salinas, Romina
dc.contributor.authorVielma, Alejandra Z.
dc.contributor.authorCastillo-Ruiz, Mario
dc.contributor.authorVelarde, Victoria
dc.contributor.authorSalgado, Magdiel
dc.contributor.authorSáez, Juan C.
dc.date.accessioned2023-11-07T20:38:42Z
dc.date.available2023-11-07T20:38:42Z
dc.date.issued2023-04
dc.descriptionINDEXACIÓN: SCOPUS.es
dc.description.abstractIndividuals with diabetes mellitus present a skeletal muscle myopathy characterized by atrophy. However, the mechanism underlying this muscular alteration remains elusive, which makes it difficult to design a rational treatment that could avoid the negative consequences in muscles due to diabetes. In the present work, the atrophy of skeletal myofibers from streptozotocin-induced diabetic rats was prevented with boldine, suggesting that non-selective channels inhibited by this alkaloid are involved in this process, as has previously shown for other muscular pathologies. Accordingly, we found a relevant increase in sarcolemma permeability of skeletal myofibers of diabetic animals in vivo and in vitro due to de novo expression of functional connexin hemichannels (Cx HCs) containing connexins (Cxs) 39, 43, and 45. These cells also expressed P2X7 receptors, and their inhibition in vitro drastically reduced sarcolemma permeability, suggesting their participation in the activation of Cx HCs. Notably, sarcolemma permeability of skeletal myofibers was prevented by boldine treatment that blocks Cx43 and Cx45 HCs, and now we demonstrated that it also blocks P2X7 receptors. In addition, the skeletal muscle alterations described above were not observed in diabetic mice with myofibers deficient in Cx43/Cx45 expression. Moreover, murine myofibers cultured for 24 h in high glucose presented a drastic increase in sarcolemma permeability and levels of NLRP3, a molecular member of the inflammasome, a response that was also prevented by boldine, suggesting that, in addition to the systemic inflammatory response found in diabetes, high glucose can promote the expression of functional Cx HCs and activation of the inflammasome in skeletal myofibers. Therefore, Cx43 and Cx45 HCs play a critical role in myofiber degeneration, and boldine could be considered a potential therapeutic agent to treat muscular complications due to diabetes. © 2023 by the authors.es
dc.identifier.citationBiomolecules, Volume 13, Issue 4, April 2023, Article number 708es
dc.identifier.doi10.3390/biom13040708
dc.identifier.issn2218273X
dc.identifier.urihttps://repositorio.unab.cl/xmlui/handle/ria/53865
dc.language.isoenes
dc.publisherMDPIes
dc.rights.licenseCC BY 4.0 DEED Attribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectcalcium atrophyes
dc.subjectconnexinses
dc.subjecthemichannel blockeres
dc.subjectsarcolemma permeabilityes
dc.titleSkeletal Muscle Atrophy Induced by Diabetes Is Mediated by Non-Selective Channels and Prevented by Boldinees
dc.typeArtículoes
Archivos
Bloque original
Mostrando 1 - 1 de 1
Miniatura
Nombre:
Skeletal-Muscle-Atrophy-Induced-by-Diabetes-Is-Mediated-by-NonSelective-Channels-and-Prevented-by-BoldineBiomolecules.pdf
Tamaño:
2.59 MB
Formato:
Adobe Portable Document Format
Descripción:
TEXTO COMPLETO EN INGLÉS
Descargar
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar
Colecciones
FM - Artículos de Revista